Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · Fidelity

Fidelity MSCI Health Care Index ETF (FHLC)

Ticker FHLC · Index fund · · Holdings as of Jul 31, 2026

Expense ratio
0.084%$8.4/yr per $10k
5-yr return
+7.2%annualized
1-yr return
+2.6%as of Nov 2025
Net assets
$3.3Ball share classes
Holdings
337

Bottom line

Is FHLC a good fund? The bottom line

FHLC is an index health care sector ETF from Fidelity.

Annual fees run 0.084% — about $8.4 a year on every $10,000 invested, cheaper than 99% of health care sector funds we track.

It returned +2.6% over one year, +7.2% a year over five years, +8.8% a year over ten (as of Nov 30, 2025, per its prospectus).

With $3.3 billion in net assets and 337 holdings, its largest position is Eli Lilly & Co (13.3%) and the top 10 make up 51.9% of the portfolio.

The closest lower-cost alternative we found is XLV (0.08%, 98% top-holdings overlap).

What stands out

  • Low cost: cheaper than 99% of health care sector peers
  • 5-year return beat 87% of category peers
  • Broadly diversified (337 holdings)

What to watch

  • Concentrated: top 10 holdings are 51.9% of assets

Updated Nov 19, 2026

What FHLC invests in

Fidelity MSCI Health Care Index ETF seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care 25/50 Index.

"Investing at least 80% of assets in securities included in the MSCI USA IMI Health Care 25/50 Index. The MSCI USA IMI Health Care 25/50 Index represents the performance of the health care sector in the U.S. equity market. The index consists of U.S. companies that are classified in the health care sector according to the GICS . The GICS health care sector encompasses two main industry groups. The first group includes companies that manufacture health care equipment and supply or provide health care related services, including distributors of health care products, providers of basic health-care services, and owners and operators of health care facilities and organizations. The second group includes companies primarily involved in the research, development, production and marketing of pharmaceuticals and biotechnology products. Effective December 11, 2025, derivative instruments that…

From the fund's prospectus (filed Nov 24, 2025).

FHLC performance

Fund calendar-year total returns, 2015–2024 2015: +7.0%; 2016: −3.3%; 2017: +23.3%; 2018: +5.5%; 2019: +21.9%; 2020: +18.1%; 2021: +20.4%; 2022: −5.5%; 2023: +2.5%; 2024: +2.6% +7% 2015 −3% 2016 +23% 2017 +6% 2018 +22% 2019 +18% 2020 +20% 2021 −5% 2022 +2% 2023 +3% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
FHLC+2.6%+7.2%+8.8%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Nov 30, 2025

Full FHLC performance history →

What FHLC costs

On a $10,000 investment, FHLC's 0.084% expense ratio costs about $8.4 a year. The prospectus estimates $108 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full FHLC fee table →

FHLC top 10 holdings

#Holding% of fund
1Eli Lilly & Co13.35%
2Johnson & Johnson8.93%
3AbbVie Inc6.42%
4UnitedHealth Group Inc5.44%
5Merck & Co Inc4.66%
6Thermo Fisher Scientific Inc3.09%
7Amgen Inc3.00%
8Abbott Laboratories2.66%
9Gilead Sciences Inc2.34%
10Pfizer Inc2.06%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 51.9% of the fund. See all top 25 holdings and asset mix →

Alternatives to FHLC

Closest equivalent at other fund companies
FamilyFundExpense ratioOverlap
SPDR (State Street)XLV State Street(R) Health Care Select…0.08%98% Compare
VanguardVHT Vanguard Health Care Index Fund0.09%94% Compare
iSharesIYH iShares U.S. Healthcare ETF0.37%91% Compare
J.P. MorganJDOC JPMorgan Healthcare Leaders ETF0.65%63% Compare
SchwabSWHFX Schwab Health Care Fund0.8%76% Compare
T. Rowe PricePRHSX T. Rowe Price Health Sciences Fund, Inc.0.83%78% Compare

More funds like FHLC →

FHLC FAQ

What is the expense ratio of FHLC?
FHLC's expense ratio is 0.084%, which works out to about $8.4 a year for every $10,000 invested. The prospectus estimates total costs of $108 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is FHLC a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 99% of health care sector peers; 5-year return beat 87% of category peers; broadly diversified (337 holdings); concentrated: top 10 holdings are 51.9% of assets. This is general information, not personalized advice.
What does FHLC hold?
FHLC's largest holdings are Eli Lilly & Co (13.3%), Johnson & Johnson (8.9%), AbbVie Inc (6.4%), UnitedHealth Group Inc (5.4%), Merck & Co Inc (4.7%). It holds 337 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is FHLC's 5-year return?
FHLC returned +7.2% a year over the five years ending Nov 30, 2025, and +8.8% a year over ten years. Past performance does not guarantee future results.
What is a cheaper alternative to FHLC?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) overlaps about 98% with FHLC and charges 0.08%.
Who manages FHLC?
FHLC is offered by Fidelity through Fidelity Covington Trust.